Replay available

Fennec Pharmaceuticals Inc. (FENC) Q4 2025 Earnings Call

Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Q4 2025 earnings conference call, held 2026-03-24. Replay captured from the company's public earnings webcast.

Tue, March 24, 2026 at 8:30 AMendedReplay
Fennec Pharmaceuticals Inc. (FENC) Q4 2025 Earnings Call

Hosted by

Featured presenters

Robert Andrade

Chief Financial Officer

Jeff Hackman

Chief Executive Officer

Dr. Pierre Sayad

Chief Medical Officer

Ram Sabaraju

Analyst, H.C. Wainwright

Jason Ikebaka

Analyst, CREPAL

Sudan Ligonettan

Analyst, Stephens Inc.

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Fennec Pharmaceuticals Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.957 Good morning, ladies and gentlemen. Welcome to FENIC Pharmaceuticals' fourth quarter 00:00:03.957 -- 00:00:08.423 and four-year 2025 earnings and corporate update conference call. 00:00:08.423 -- 00:00:11.949 At this time, all participants are on a listen-only mode. 00:00:11.949 -- 00:00:16.375 Later, we will conduct a question-and-answer session, and instructions on how to participate 00:00:16.375 -- 00:00:22.064 will be given at that time. As a reminder, today's conference call is being recorded. 00:00:22.064 -- 00:00:28.310 Now I'd like to turn the conference over to FENIC's Chief Financial Officer, Robert Andrade. 00:00:28.834 -- 00:00:32.204 Thank you, Operator. and good morning, everyone. 00:00:32.204 -- 00:00:37.489 Thank you for joining us today. We are pleased to host Phenix Pharmaceuticals' fourth 00:00:37.489 -- 00:00:40.171 quarter and full year 2025 00:00:40.171 -- 00:00:45.056 earnings conference call, during which we will review our financial results as well as 00:00:45.056 -- 00:00:48.019 provide a general business update. 00:00:48.019 -- 00:00:53.243 Towards the end of the call, we will conduct a Q&A session hosted by myself, 00:00:53.243 -- 00:00:57.608 starting with frequent questions that the company receives from investors. 00:00:57.608 -- 00:01:01.992 followed by our traditional open Q&A session. 00:01:01.992 -- 00:01:07.098 Joining me from Fennec this morning is our Chief Executive Officer and Board Member, 00:01:07.098 -- 00:01:08.879 Jeff Hackman. 00:01:08.879 -- 00:01:13.584 I am also pleased to welcome our Chief Medical Officer, Dr. 00:01:13.584 -- 00:01:15.826 Pierre Sayad. 00:01:15.826 -- 00:01:21.052 Pierre is an accomplished industry executive with proven success leading global 00:01:21.052 -- 00:01:2...